A real world retrospective chart review in patients with diabetic macular edema receiving ILUVIEN®

Trial Profile

A real world retrospective chart review in patients with diabetic macular edema receiving ILUVIEN®

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions
  • Acronyms USER
  • Most Recent Events

    • 08 Nov 2017 According to an Alimera Sciences media release, updated data from this trial will be presented at 2017 Annual Meeting of the American Academy of Ophthalmology (AAO).
    • 07 Nov 2017 According to an Alimera Sciences media release, data from this trial will be presented at the Ophthalmology Innovation Summit (OIS) 2017.
    • 09 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top